Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

Go back to Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
(NASDAQ: TRVI) Delayed: 14.46 +1.00 (7.43%)
Previous Close $13.46    52 Week High
Open $13.55    52 Week Low
Day High $14.72    P/E N/A 
Day Low $13.52    EPS
Volume 463,667